Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-28 Purchase | 2023-11-30 4:05 pm | Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director | 10,000 | $0.6486 | $6,486 | 50,000 (Direct) | View |
| 2023-11-21 Purchase | 2023-11-22 4:06 pm | Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director | 10,000 | $0.6383 | $6,383 | 40,000 (Direct) | View |
| 2023-11-16 Purchase | 2023-11-20 8:14 pm | Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director | 30,000 | $0.608 | $18,240 | 30,000 (Direct) | View |
| 2022-12-05 Purchase | 2022-12-07 4:29 pm | PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer | 12,500 | $1.09 | $13,625 | 50,000 (Direct) | View |
| 2022-12-01 Purchase | 2022-12-05 4:21 pm | PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer | 37,500 | $1.05 | $39,375 | 37,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-10 6:20 pm | 2025-06-06 2034-06-06 | Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 9:45 pm | N/A 2034-06-05 | Annexon Inc. | ANNX | WIGGANS THOMAS G Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 4:54 pm | N/A 2031-04-04 | CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director | 186,010 | $0 | 0 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:18 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director | 14,010 | $0 | 14,010 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-02 6:00 pm | N/A 2033-11-01 | Jasper Therapeutics Inc. | JSPR | WIGGANS THOMAS G Director | 110,000 | $0 | 110,000 (Direct) | View |
| 2023-08-31 Equity Swap | 2023-08-31 2:55 pm | N/A N/A | PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer | 50,000 | $0 | 0 (Direct) | View |
| 2023-08-31 Disposition | 2023-08-31 2:55 pm | N/A 2033-01-31 | PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer | 1,997,500 | $0 | 0 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:50 pm | N/A 2033-06-08 | Annexon Inc. | ANNX | WIGGANS THOMAS G Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:36 pm | N/A 2033-02-01 | PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer | 562,500 | $0 | 562,500 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 4:34 pm | N/A 2033-01-24 | CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-10-14 Equity Swap | 2022-10-14 4:06 pm | N/A N/A | Forma Therapeutics Holdings Inc. | FMTX | WIGGANS THOMAS G Director | 7,250 | $0 | 0 (Direct) | View |
| 2022-10-14 Disposition | 2022-10-14 4:06 pm | N/A N/A | Forma Therapeutics Holdings Inc. | FMTX | WIGGANS THOMAS G Director | 40,125 | $0 | 0 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 4:17 pm | N/A 2032-09-14 | PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:44 pm | N/A 2032-06-09 | Annexon Inc. | ANNX | WIGGANS THOMAS G Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:34 pm | N/A 2032-06-07 | Forma Therapeutics Holdings Inc. | FMTX | WIGGANS THOMAS G Director | 11,250 | $0 | 14,000 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 4:40 pm | N/A 2032-03-01 | PARDES BIOSCIENCES INC. | PRDS | WIGGANS THOMAS G Chief Executive Officer | 985,000 | $0 | 985,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:54 pm | N/A 2032-01-24 | CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 7:05 pm | N/A 2031-06-16 | Forma Therapeutics Holdings Inc. | FMTX | WIGGANS THOMAS G Director | 11,125 | $0 | 11,125 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:12 pm | N/A 2031-06-02 | Annexon Inc. | ANNX | WIGGANS THOMAS G Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-04-05 Option Award | 2021-04-05 5:01 pm | N/A 2031-04-04 | CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-09-07 Option Award | 2020-09-09 4:05 pm | N/A 2030-09-06 | Forma Therapeutics Holdings Inc. | FMTX | WIGGANS THOMAS G Director | 25,000 | $0 | 0 (Direct) | View |
Ownership | 2020-07-23 4:57 pm | N/A 2027-02-28 | Annexon Inc. | ANNX | WIGGANS THOMAS G Director | 0 | $0 | 31,745 (Direct) | View |
| 2020-02-05 Gift | 2020-02-24 7:31 pm | N/A N/A | Dermira Inc. | DERM | WIGGANS THOMAS G CEO & Chairman of the Board | 27,000 | $0 | 0 (Direct) | View |
| 2020-02-20 Disposition | 2020-02-24 7:31 pm | N/A 2021-10-03 | Dermira Inc. | DERM | WIGGANS THOMAS G CEO & Chairman of the Board | 1,681,591 | $0 | 0 (Direct) | View |
| 2020-02-20 Disposition | 2020-02-24 7:31 pm | N/A N/A | Dermira Inc. | DERM | WIGGANS THOMAS G CEO & Chairman of the Board | 230,948 | $18.75 | 0 (Direct) | View |